NCT00378911View on ClinicalTrials.gov

Sunitinib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus

PHASE2CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

June 30, 2007

Study Completion Date

January 31, 2010

Conditions
Recurrent Uterine SarcomaUterine Leiomyosarcoma
Interventions
DRUG

sunitinib malate

Given orally

Trial Locations (1)

19103

Gynecologic Oncology Group, Philadelphia

All Listed Sponsors
collaborator

Gynecologic Oncology Group

NETWORK

lead

National Cancer Institute (NCI)

NIH

NCT00378911 - Sunitinib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus | Biotech Hunter | Biotech Hunter